30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Performance

Overall performance
2.1

Performance over holding periods
2.1
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 15% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Director ImClone LLC Nov. 21, 2008 -
Independent Chairman of the Board AMAG Pharmaceuticals Inc April 14, 2014 -
Independent Director Allena Pharmaceuticals Inc Feb. 1, 2012 -
Lead Independent Director Collegium Pharmaceutical Inc May 1, 2015 -
Lead Independent Director Intercept Pharmaceuticals Inc Feb. 1, 2018 -
Independent Director Horizon Therapeutics PLC March 1, 2012 - April 30, 2020
Independent Director Intercept Pharmaceuticals Inc Nov. 14, 2015 - Feb. 1, 2018
Director Vitae Pharmaceuticals LLC Sept. 1, 2014 - Oct. 25, 2016
Independent Director Collegium Pharmaceutical Inc July 1, 2012 - May 1, 2015
Independent Director AMAG Pharmaceuticals Inc Feb. 7, 2012 - April 14, 2014

Gino Santini's trades of Collegium Pharmaceutical Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-08-19 2025-08-15 S Sale
70,800 +32.4%
463.44
US$2,233,547
70,800 +32.4% 463.44 US$2,233,547
2025-08-15 2025-08-15 PrS Proposed sale
3,350
135.08
US$2,635,753
3,350 135.08 US$2,635,753
2021-03-03 2021-03-01 S Sale
90,852 +12.9%
311.90
US$1,011,193
90,852 +12.9% 311.90 US$1,011,193